Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Stella, Ha"'
Autor:
Sung Hoon, Noh, Sook Ryun, Park, Han-Kwang, Yang, Hyun Cheol, Chung, Ik-Joo, Chung, Sang-Woon, Kim, Hyung-Ho, Kim, Jin-Hyuk, Choi, Hoon-Kyo, Kim, Wansik, Yu, Jong Inn, Lee, Dong Bok, Shin, Jiafu, Ji, Jen-Shi, Chen, Yunni, Lim, Stella, Ha, Yung-Jue, Bang, S-Y, Chen
Publikováno v:
The Lancet. Oncology. 15(12)
The CLASSIC trial was done to compare adjuvant capecitabine plus oxaliplatin versus observation after D2 gastrectomy for patients with stage II or III gastric cancer. The planned interim analysis of CLASSIC (median follow-up 34 months) showed that ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f64559561b38d069582fb45db75241ed
https://pubmed.ncbi.nlm.nih.gov/25439685
https://pubmed.ncbi.nlm.nih.gov/25439685
Autor:
Jiafu Ji, Ik-Joo Chung, Hyung Ho Kim, Han-Kwang Yang, Kyung Hee Lee, Sook Ryun Park, Stella Ha, Yunni Lim, Hyun Cheol Chung, Jen-Shi Chen, Sung Hoon Noh, Yung-Jue Bang
Publikováno v:
Annals of Oncology. 24:iv14
2twice daily days 1–14 q3w) for 8 cycles or surgery alone. The primary endpoint was 3-year disease-free survival. The clinical cut-off date for the prospectively planned final 5-year efficacy analysis was 22 November 2012. Results: At data cut-off,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::300e8ba7a71f2fb170cb1a08b8e70acb
https://doi.org/10.1093/annonc/mdt201.7
https://doi.org/10.1093/annonc/mdt201.7